{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:01:11Z","timestamp":1792108871610,"version":"4.4.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:p>Inherited forms of medullary thyroid carcinoma (MTC) can cause serious problems in diagnosis and follow-up. Family screening is performed, and prophylactic thyroidectomy at an appropriate age can be life-saving. This study aimed to investigate the diagnostic, clinical, laboratory characteristics, and treatment methods of cases with rearranged during transfection (<jats:italic toggle=\"yes\">RET)<\/jats:italic> mutation in the childhood age group. Patients diagnosed with hereditary MTC and patients who were evaluated by detecting MTC and\/or <jats:italic toggle=\"yes\">RET<\/jats:italic> mutations in their families were included in this study. Nine cases from 6 families were included in the study. Seven patients were evaluated as a result of screening, whereas 2 patients, one of whom was MEN2B, were symptomatic. Prophylactic thyroidectomy was performed in 7 cases. Medullary microcarcinoma was found in all, and additional papillary thyroid carcinoma in one. An inoperable tumor was detected in one patient, and sorafenib treatment was applied. A very heterogeneous clinical presentation can be seen in a group of pediatric patients with <jats:italic toggle=\"yes\">RET<\/jats:italic> mutation. In rare <jats:italic toggle=\"yes\">RET<\/jats:italic> mutations, the genotype-phenotype relationship is still unclear, and different clinical pictures can be seen. Although prophylactic thyroidectomy is life-saving, it can cause iatrogenic hypothyroidism and hypoparathyroidism. Concomitant papillary microcarcinomas may occur in very young children with germline <jats:italic toggle=\"yes\">RET<\/jats:italic> mutation.<\/jats:p>","DOI":"10.1097\/mph.0000000000002728","type":"journal-article","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T09:03:43Z","timestamp":1690880623000},"page":"e789-e797","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Clinic Heterogeneity and Management of Pediatric Patients With Germline RET Proto-oncogene Mutation: Single-center Experience"],"prefix":"10.1097","volume":"45","author":[{"given":"Zeynep","family":"\u015e\u0131klar","sequence":"first","affiliation":[{"name":"Pediatric Endocrinology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tu\u011fba","family":"Kontbay","sequence":"additional","affiliation":[{"name":"Pediatric Endocrinology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Handan","family":"Dincaslan","sequence":"additional","affiliation":[{"name":"Pediatric Oncology, Ankara University School of Medicine, Cebeci, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emel","family":"\u00dcnal","sequence":"additional","affiliation":[{"name":"Pediatric Oncology, Ankara University School of Medicine, Cebeci, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merih","family":"Berberoglu","sequence":"additional","affiliation":[{"name":"Pediatric Endocrinology"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,7,24]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s10897-018-0273-1","article-title":"Utilization of genetic testing for RET mutations in patients with medullary thyroid carcinoma: a single-center experience","volume":"27","author":"Parkhurst","year":"2018","journal-title":"J Genet Couns"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1089\/thy.2015.0673","article-title":"A nationwide study of multiple endocrine neoplasia type 2A in Norway: predictive and prognostic factors for the clinical course of medullary thyroid carcinoma","volume":"26","author":"Opsahl","year":"2016","journal-title":"Thyroid"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"590","DOI":"10.24953\/turkjped.2017.05.014","article-title":"Child with RET proto-oncogene codon 634 mutation","volume":"59","author":"\u0130nce","year":"2017","journal-title":"Turk J Pediatr"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"American Thyroid Association Guidelines task force on medullary thyroid carcinoma. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"e28171","DOI":"10.1002\/pbc.28171","article-title":"Revisiting the genotype-phenotype correlation in children with medullary thyroid carcinoma: a report from the GPOH-MET registry","volume":"67","author":"Kuhlen","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1186\/s12885-021-08116-9","article-title":"Spectrum of germline RET variants identified by targeted sequencing and associated multiple endocrine neoplasia type 2 susceptibility in China","volume":"21","author":"Qi","year":"2021","journal-title":"BMC Cancer"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.ejso.2018.09.002","article-title":"Prophylactic thyroidectomy in multiple endocrine neoplasia 2 (MEN2) patients with the C634Y mutation: a long-term follow-up in a large single-center cohort","volume":"45","author":"Febrero","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2265.2007.03153.x","article-title":"Familial prevalence and age of RET germline mutations: implications for screening","volume":"69","author":"Machens","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4274\/jcrpe.2219","article-title":"Distribution of RET mutations and evaluation of treatment approaches in hereditary medullary thyroid carcinoma in Turkey","volume":"8","author":"Aydo\u011fan","year":"2016","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"E92","DOI":"10.1210\/jc.2010-0375","article-title":"The clinical spectrum of multiple endocrine neoplasia type 2a caused by the rare intracellular RET mutation S891A","volume":"95","author":"Schulte","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"33993","DOI":"10.18632\/oncotarget.4992","article-title":"RET mutation p.S891A in a Chinese family with familial medullary thyroid carcinoma and associated cutaneous amyloidosis binding OSMR variant p.G513D","volume":"6","author":"Qi","year":"2015","journal-title":"Oncotarget"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12920-019-0552-1","article-title":"Retroposed copies of RET gene: a somatically acquired event in medullary thyroid carcinoma","volume":"12","author":"Bim","year":"2019","journal-title":"BMC Med Genomics"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3892\/mco.2021.2450","article-title":"Four cases of medullary thyroid carcinomas associated with multiple endocrine neoplasia 2B with rearranged during transfection codon M918T mutation in the same family","volume":"16","author":"Tanaka","year":"2022","journal-title":"Mol Clin Oncol"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1210\/jc.2011-2534","article-title":"Biological relevance of medullary thyroid microcarcinoma","volume":"97","author":"Machens","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R15-20250804","first-page":"171","article-title":"Synchronous papillary thyroid carcinoma and medullary thyroid carcinoma\u2014a pitfall waiting to happen","volume":"39","author":"Tang","year":"2017","journal-title":"Malays J Pathol"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/hed.20984","article-title":"Mixed medullary-papillary carcinoma of the thyroid: report of a case and review of the literature","volume":"31","author":"Nangue","year":"2009","journal-title":"Head Neck"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1365-2265.2009.03622.x","article-title":"Concurrent occurrence of medullary thyroid carcinoma and papillary thyroid carcinoma in the same thyroid should be considered as coincidental","volume":"72","author":"Kim","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1752-1947-1-133","article-title":"Simultaneous medullary and papillary thyroid cancer: two case reports","volume":"1","author":"Dionigi","year":"2007","journal-title":"J Med Case Rep"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s12022-017-9491-6","article-title":"Synchronous and metastatic papillary and follicular thyroid carcinomas with unique molecular signatures","volume":"29","author":"Cracolici","year":"2018","journal-title":"Endocr Pathol"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1752-1947-7-26","article-title":"Simultaneous occurrence of medullary and papillary thyroid microcarcinomas: a case series and review of the literature","volume":"7","author":"Adnan","year":"2013","journal-title":"J Med Case Rep"},{"key":"R21-20250804","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijscr.2020.06.070","article-title":"Simultaneous occurrence of follicular and papillary thyroid carcinomas in same thyroid lobe: a case series of six patients from Qatar","volume":"73","author":"Abdelaal","year":"2020","journal-title":"Int J Surg Case Rep"},{"key":"R22-20250804","doi-asserted-by":"crossref","first-page":"E125","DOI":"10.1002\/dc.24615","article-title":"Cytologic features of a case of mixed medullary and follicular cell-derived thyroid carcinoma with review of the literature","volume":"49","author":"Chambers","year":"2021","journal-title":"Diagn Cytopathol"},{"key":"R23-20250804","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s12022-015-9381-8","article-title":"Case of concurrent MTC and PTC in a patient with a germline RET mutation","volume":"26","author":"Shah","year":"2015","journal-title":"Endocr Pathol"},{"key":"R24-20250804","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/s12022-014-9303-1","article-title":"Synchronous occurrence of medullary and papillary carcinoma of the thyroid in a patient with cutaneous melanoma: determination of BRAFV600E in peripheral blood and tissues. Report of a case and review of the literature","volume":"25","author":"Fibbi","year":"2014","journal-title":"Endocr Pathol"},{"key":"R25-20250804","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1440-1827.2006.01928.x","article-title":"Mixed medullary and follicular cell carcinoma of the thyroid with lymph node metastasis in a 7-year-old child","volume":"56","author":"Goyal","year":"2006","journal-title":"Pathol Int"},{"key":"R26-20250804","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1055\/a-1145-8479","article-title":"Update on the treatment of medullary thyroid carcinoma in patients with multiple endocrine neoplasia type 2","volume":"52","author":"Ilanchezhian","year":"2020","journal-title":"Horm Metab Res"},{"key":"R27-20250804","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1055\/s-0044-100378","article-title":"First line sorafenib treatment for metastatic medullary thyroid cancer: efficacy and safety analysis","volume":"127","author":"Kocsis","year":"2019","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"R28-20250804","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1089\/thy.2015.0334","article-title":"Sorafenib for the treatment of progressive metastatic medullary thyroid cancer: efficacy and safety analysis","volume":"26","author":"de Castroneves","year":"2016","journal-title":"Thyroid"},{"key":"R29-20250804","doi-asserted-by":"crossref","first-page":"T1","DOI":"10.1530\/ERC-17-0325","article-title":"Advances in the management of MEN2: from improved surgical and medical treatment to novel kinase inhibitors","volume":"25","author":"Wells","year":"2018","journal-title":"Endocr Relat Cancer"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002728","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:07:05Z","timestamp":1754338025000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,24]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002728","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,24]]},"assertion":[{"value":"2022-01-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}